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Background: Non alcoholic fatty liver disease (NAFLD) is an independent cardiovascular (CV) risk factor which is
closely associated with insulin resistance measured by both direct or indirect methods. Gender specific findings in
the relationship between alanine aminotransferase (ALT) and CV disease, the prevalence of NAFLD and type 2
diabetes (T2DM) have been published recently.
The aim of the present study was to explore the gender aspects of the association between insulin sensitivity, liver
markers and other metabolic biomarkers in order to elucidate the background behind the sex influenced difference
in both NAFLD, T2DM and their association with CV risk.
Patients and methods: 158 female (47 normal and 111 impaired glucose intolerant) and 148 male (74 normal and 74
impaired glucose tolerant) subjects were included (mean age: 46.5 ± 8.31 vs. 41.6 ± 11.3, average Hba1c < 6.1 %, i.e.
prediabetic population, drug naive at the time of the study). Subjects underwent a hyperinsulinemic normoglycemic
clamp to determine muscle glucose uptake (M3), besides liver function tests and other fasting metabolic and
anthropometric parameters were determined.
Results: Significant bivariate correlations were found between clamp measured M3 and all three liver enzymes (ALT,
aspartate aminotransferase and gamma-glutamyl transferase) in both sexes. When data were adjusted for possible
metabolic confounding factors correlations ceased in the male population but stayed significant in the female group.
Feature selection analysis showed that ALT is an important attribute for M3 in the female but not in male group (mean
Z: 3.85 vs. 0.107). Multiple regression analysis confirmed that BMI (p < 0.0001) and ALT (p = 0.00991) significantly and
independently predicted clamp measured muscle glucose uptake in women (R2 = 0.5259), while in men serum fasting
insulin (p = 0.0210) and leptin levels (p = 0.0294) but none of the liver enzymes were confirmed as significant independent
predictors of M3 (R
2 = 0.4989).
Conclusion: There is a gender specific association between insulin sensitivity, metabolic risk factors and liver transaminase
levels. This might explain the sex difference in the predictive role of ALT elevation for CV disease. Moreover, ALT may be
used as a simple diagnostic tool to identify insulin resistant subjects only in the female population according to our
results.
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Men are well known to have a higher risk of cardiovas-
cular disease than women. In recent years, studies have
shown that adult men also have a higher risk of type 2
diabetes (T2DM) [1] and higher prevalence rates for
non-alcoholic fatty acid liver disease (NAFLD) [2], while
they seem to have to gain less weight to develop T2DM
than do women [3]. Moreover, elevated ALT, an indica-
tor of the presence of NAFLD is found to be a predictor
of coronary heart disease (CHD) only in men [4]. T2DM
is associated with increased cardiovascular risk factors in
both genders but diabetic women show a greater relative
increase than diabetic men [5]. It is proposed that women
have to undergo greater metabolic deterioration than men
to develop type 2 diabetes and as such many insulin resist-
ance risk factors must change to a greater extent [1]. This
can be explained by the notion that adult men are more
insulin resistant than women [6], since women appear to
have better ability to expand safer subcutaneous fat stores;
hence they can remain highly insulin sensitive despite con-
siderable weight gain [7]. This capacity is lower in men,
where ectopic fat appears to accumulate more in the
intra-abdominal and perivascular cells, skeletal muscle,
liver and possibly pancreas.
Rising waist circumference and rising liver enzymes, in
particular alanine aminotransferase (ALT) and gamma-
glutamyl transferase (GGT), especially in conjunction with
parallel triglyceride (TG) changes, indicate liver fat gain
[8–10]. Indeed, clinical studies have associated ALT levels
with insulin resistance (IR), the metabolic syndrome (MetS)
and the development of T2DM [11–13]. A number of stud-
ies have reported a positive association between serum ALT
levels and IR using indirect parameters such as the Homeo-
static Model Assessment (HOMA-IR) [12, 13], or direct
methods, such as the hyperinsulinemic normoglycaemic
clamp or minimal model analysis [11, 14]. Also, there is
an independent association between the hepatic IR
index and ALT levels in subjects with MetS, impaired
fasting glucose, impaired glucose tolerance (IGT) and
T2DM [15]. In non-obese subjects, the ALT/AST ratio
has been found to be the most reliable marker of IR,
while in obese subjects it predicted IR better than con-
ventional atherogenic markers such as LDL-C/HDL-C
or TG/HDL-C [16].
A gender difference in the association between liver en-
zymes and IR was found recently in the adolescent popu-
lation [17]. Although this difference is well described in
the pathogenesis of T2DM in adults, and the prevalence
of NAFLD, which often occurs as an accompanying dis-
ease for T2DM, gender aspects of the connection between
liver function changes and directly measured insulin sensi-
tivity in the adult population have not been addressed
before, or only secondary findings indicate the existence of
such difference.The aim of our study was to carry out a sex-specific ana-
lysis in association with clamp-measured insulin sensitivity
and liver function test connections in a normal glucose-
tolerant/prediabetic population. We also sought to deter-
mine the gender difference in liver function changes,
based on phenotypic and genetic susceptibility to MetS
and T2DM. Therefore we included a cohort of healthy
and prediabetic male and female subjects, genetically pre-
disposed or not predisposed to diabetes (i.e. having a dia-
betic first-degree relative in the family). Male and female
subjects were analyzed separately. No such data have been
published before.
Methods
Patients
Data were retrospectively analyzed from a scientific study
approved by the Hungarian Central Ethical Committee
(A12988-2/2003-1018-EKU) titled” Diagnostic investiga-
tion for the early recognition of insulin resistance
syndrome and its complications (granted by Hungar-
ian National Research and Innovation Program:
NKFB -1B/0007/2002). Patients’ recruitment started in
2004 and ended in 2008. After obtaining signed informed
consent, 158 women and 148 men were included in the
study, as approved by the ethical committee. Subjects were
classified based on the results of a standard 75 grams oral
glucose tolerance testing (OGTT) at screening (blood
drawn in the 0, 30, 60, 90 and 120 min), according to
the American Diabetes Association criteria [18]. We
included 47 normal glucose-tolerant (NGT) and 111
glucose-intolerant (GI) subjects in the female group; in
the male group, there were 74 NGT and 74 GI subjects.
Patients and healthy volunteers were recruited from
our own diabetes outpatient clinic and by referral from
regional GPs. All GI patients, which included impaired
fasting glucose (IFG), impaired glucose-tolerant (IGT)
and T2DM patients, were drug-naive at the time of the
study. Patients receiving antidiabetic medication or
hormone substitution therapy, or suffering from any
known liver disease, were excluded from the study.
Subjects with excessive alcohol consumption were also
excluded, although we have excluded those who con-
sumed even moderate or small amounts of alcohol for
specific analyses of age and metabolically adjusted
subpopulations.
OGTT, IVGTT and clamp
All subjects fasted on the day of the clamp examination.
They first underwent an intravenous glucose tolerance test-
ing (IVGTT) examination to assess insulin secretion (0.3 g/
bodyweight iv. glucose injection). Following the IVGTT, a
hyperinsulinaemic normoglycaemic clamp examination was
carried out, as described by DeFronzo et al. [19]. During a
continuous infusion of insulin (45 mU × min × m−2) and
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cose infusion rate (earliest from the 120th minute of
clamp), where blood sugar level stayed between 5.0 and
5.9 mM/l for at least 30 min after the beginning of steady
state. Glucose and insulin levels were measured from
venous blood at 3-, 5-, 10-, 20-, 30-, 40-, 50- and 60 min
samples of IVGTT, before the beginning, and the 0-, 10-
20-, 30 min samples of the steady state of clamp. Insulin
secretion was determined from IVGTT by the insulogenic
index [Δ (insulin5’-insulin3’)/Δ (glucose5’-glucose3’)] and
the AIR (acute insulin response: [(insulin5’ + insulin3’)/
2 – insulin0’)], both being sensitive indicators of first-
phase insulin response, and hence the real beta cell func-
tion. HIRI (hepatic insulin resistance index) was estimated
from the OGTT 0 and 30 min glucose and insulin values
[HIRI = (GLU-AUC) × (Ins-AUC) 0-30’] described by
Muhammad et al. [20]. Glucose and insulin area under
the curve (AUC) values were calculated using the trap-
ezoidal rule, both from OGTT and IVGTT. We used
lean body (LB = muscle)-adjusted glucose uptake (M3
value, mg/min/kgLB) calculated from the glucose infu-
sion rates during clamp, to measure peripheral (muscle)
insulin sensitivity. Formula for calculation of serum
glucose levels from mmol/l to mg/dl for the clamp M3
value: mg/dl = 18 × mmol/l. Body composition was de-
termined by dual-energy X-ray absorptiometry (DPX-
MD+, GE-Lunar, USA, Florida).Biochemical measurements
Routine biochemical parameters were measured on Cobas
Mira and Hitachi 912 laboratory automats with the same
method (according to IFCC recommendations) during the
recruitment period (2003 – 2008). Reference ranges, detec-
tion limits and test principles were unchanged during this
test period. Alanine aminotransferase (ALT), aspartate ami-
notransferase (AST), gamma-glutamyltransferase (GGT),
alkaline phosphatase (ALP), serum bilirubin, (ALP and
serum bilirubin only used in feature selection analysis), free
fatty acid (FFA), insulin, glucose, HbA1c levels and conven-
tional lipid parameters were determined using Roche re-
agents (Roche Diagnostics, Germany).
Measurements of specific serum parameters (such as
hormones, lipid fractions etc.) were performed at the same
time and with the same tests. Total estradiol, testoster-
one, FSH and serum insulin levels were measured with
an Elecsys 2010 electrochemiluminescense automat
(Roche Diagnostic, Germany). Serum leptin, adiponec-
tin, interleukin-6 (IL-6) and tumor necrosis factor-α
(TNF-α) levels were measured by the enzyme-linked
immunosorbent method (Quantikine DLP00, Quan-
tikine DRP300, Quantikine HS600B and Quantikine
HSTA00D kits respectively; R&D Systems, Minneapolis,
MN, USA,). Lipid fractionation was done by the LipoprintSystem® (Quantimetrix, USA). Lipid subfractions (very low
density lipoproteins [VLDL], intermediate-density lipopro-
teins [IDL-A, −B and –C], and low-density lipoproteins
[LDL1 − 4 subfractions, LDL 2–4 subfractions = small-
dense LDL]), total LDL and high-density lipoprotein
[HDL] were separated by gel electrophoresis.Statistics
All statistical analyses were performed with R Statistical
Software (version 3.1.0). The calculated descriptive sta-
tistics was the mean, standard deviation, median and
mean absolute deviation (MAD) for each value pre-
sented as not all variables were normally distributed.
Sample size determination was done empirically based
on other clamp studies in the original protocol. We have
used boot strap analysis (Monte-Carlo simulation) to
test the minimal sample number to determine statistical
differences between groups. The Wilcoxon rank sum
test was used to assess group differences of biochemical
and anthropometric parameters as most variables were
not normally distributed. For Spearman’s correlation
coefficients were calculated to determine the strength of
association between liver enzymes and other metabolic
parameters. Partial correlation coefficients were used to
assess the influence of age, body mass index (BMI), body
fat percentage (BFP), HbA1c, FSH (women) and alcohol
consumption on significant correlations. A p value of ≤0.05
was considered significant.
After screening the male and female population for
specific filters, homogenous subpopulations were formed
matched for general metabolic features in both sexes (i.e.
subpopulations did not differ in age, BMI, body fat per-
cent, AC and HbA1c), when comparing subjects genetic-
ally disposed and not disposed to diabetes (GD vs. GND
groups). Wilcoxon rank sum test test was used to com-
pare selected subpopulations for individual features as
not all parameters were normally distributed.
The Boruta algorithm was used to find the most im-
portant attributes that are related to the M3 value. This
algorithm is a wrapper built around the randomForest
classification algorithm (implemented in the R package
randomForest) [21]. The randomForest algorithm is an
ensemble approach (divide and conquer approach); it
grows many decision trees and it gives a numerical esti-
mate of the importance of a feature. A Z score is used as
the importance measure since it takes into account the
fluctuations of the mean accuracy loss among trees in
the forest. To avoid random fluctuations in determin-
ing the importance of any given attribute, a reference
set of ‘shadow attributes’ is used for deciding which
attributes are truly important, since the importance of
a shadow attribute can be non-zero only due to ran-
dom fluctuations [22].
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to determine the ability of the attributes selected by
the Boruta algorithm to predict clamp M3. Multiple
linear regression models as functions of explanatory
variables were identified for men and women groups
(see ‘Results’).Table 1 Baseline biochemical and clinical characteristics of male and
absolute deviation (MAD)
NGT males (n = 74)
Mean ± SD Median
Age (years) 33.43 ± 11.60 30.00
BMI (kg/m2) 26.66 ± 5.01 25.10
AC (cm) 94.54 ± 13.11 90.50
HbA1C (%) 5.41 ± 0.43 5.40
Glu-0 (mmol/L) 4.89 ± 0.72 4.83
M3 (mg/min/kg) 8.83 ± 3.10 8.81
HIRI 54.42 ± 33.06 48.86
TG (mmol/l) 1.46 ± 1.14 1.07
HDL-C (mmol/L) 1.35 ± 0.40 1.36
LDL-C (mmol/L) 2.48 ± 0.83 2.31
AST (U/L) 21.68 ± 5.44 20.00
ALT (U/L) 24.81 ± 10.56 22.00
GGT (U/L) 26.93 ± 15.73 22.00
Alcohol (g/day) 0.09 ± 0.38 0.00
Hypertension (%) 10.81 NA
Smoking (%) 14.86 NA
Genetic predisposition (%) 21.62 NA
NGT females (n = 47)
Age (years) 45.10 ± 10.39 46.00
BMI (kg/m2) 26.85 ± 4.25 26.57
AC (cm) 91.95 ± 12.18 92.00
HbA1C (%) 5.62 ± 0.50 5.60
Glu-0 (mmol/L) 5.08 ± 0.49 5.08
M3 (mg/min/kg) 6.64 ± 3.24 6.29
HIRI 63.07 ± 32.51 54.76
TG (mmol/l) 1.43 ± 0.83 1.24
HDL-C (mmol/L) 1.48 ± 0.55 1.49
LDL-C (mmol/L) 2.65 ± 0.81 2.51
AST (U/L) 23.00 ± 9.76 21.00
ALT (U/L) 21.79 ± 14.21 20.00
GGT (U/L) 25.95 ± 28.13 19.00
Alcohol (g/day) 0.14 ± 0.55 0.00
Hypertension (%) 23.40 NA
Smoking (%) 14.86 NA
Genetic predisposition (%) 21.62 NA
Significant differences between groups are indicated (Wilcoxon rank sum test, *: p <
hypertension is indicated in percentageResults
General characteristics of the population are shown in
Table 1. Mean HbA1c values were under 6.1 % in all
groups, i.e. the population consisted of either normal
glucose tolerant or mostly prediabetic (IGT/IFG or fresh
T2DM) subjects, both slightly overweight and obesefemale populations. All values are means, medians and mean
GI males (n = 74)
MAD Mean ± SD Median MAD
10.46 48.72 ± 9.33** 51.40 7.75
2.42 29.99 ± 4.30** 29.41 4.01
6.67 105.07 ± 14.55** 105.00 9.64
0.44 5.90 ± 0.68** 5.80 0.59
0.56 6.09 ± 1.04** 5.96 0.96
2.82 5.88 ± 2.77** 5.74 2.38
24.98 63.86 ± 33.84** 60.24 32.09
0.55 2.65 ± 2.18** 2.00 1.33
0.36 1.13 ± 0.42** 1.08 0.29
0.80 3.00 ± 1.05** 3.03 0.79
4.45 27.57 ± 12.93** 25.00 8.90
7.41 36.24 ± 26.98** 29.50 15.57
10.38 48.44 ± 33.50** 39.00 28.17
0.00 0.30 ± 0.67** 0.00 0.00
NA 43.24 NA NA
NA 20.22 NA NA
NA 32.89 NA NA
GI females (n = 111)
10.43 50.80 ± 8.54** 53.00 7.41
4.74 31.49 ± 5.25** 31.57 4.96
14.08 104.42 ± 12.49** 103.00 11.86
0.59 6.06 ± 0.63** 6.02 0.62
0.44 5.75 ± 0.77** 5.65 0.76
2.79 4.36 ± 2.08** 3.92 1.69
27.80 75.23 ± 49.42** 60.77 36.46
0.43 1.79 ± 0.81** 1.57 0.74
0.61 1.33 ± 0.51 1.27 0.36
0.61 3.20 ± 1.06** 3.17 0.87
5.93 23.75 ± 10.37 20.00 4.45
10.38 25.33 ± 12.98* 22.00 8.90
11.86 31.76 ± 25.29** 25.00 11.86
0.00 0.02 ± 0.15 0.00 0.00
NA 43.24 NA NA
NA 18.18 NA NA
NA 36.36. NA NA
0.05, **: <0.01). The prevalence of genetic predisposition to T2DM,
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insulin sensitive than women in both (NGT and GI)
groups, although there were a lower prevalence of gen-
etic predisposition in the NGT male group. The preva-
lence of genetic predisposition (the presence of diabetes
in 1st degree relatives, GD vs. GND groups) were be-
tween 20 and 40 %, lowest in the male NGT group, as
indicated. Significant differences were found between
age and metabolic parameters in NGT vs. GI groups in
both genders as expected. ALT and GGT levels were
higher in the GI vs. NGT groups in both sexes, AST
levels differed significantly only in the male group be-
tween NGT and GI subjects.
Following the exclusion of subjects with even mild to
moderate alcohol consumption, age and BMI matched
homogenous subpopulations either with or without dia-
betic genetic background (GD vs. GND group) were
compared within sexes as described in “Statistics”. Age,
BMI and abdominal circumference did not differ signifi-
cantly between groups (Fig. 1). Furthermore, body fat
percent, HbA1c, M3 and sex hormone levels were alsoFig. 1 Boxplot diagrams for comparison of metabolic parameters and liver
Homogenous subpopulations were formed for group comparisons betwee
males n = 60, GD females n = 58, GND males n = 91). No significant differen
between GD and GND groups. Moreover body fat percentage, insulin sens
not differ significantly between groups (data not shown). Even small or mo
GD males ALT, adiponectin and IL-6 values were significantly higher than in
males. In females no significant difference was noted, except for IL-6, whichsimilar (data not shown). In males, significant difference
was found between ALT levels of GD and GND sub-
groups (Fig. 1). Moreover, IL-6 levels were significantly
higher, adiponectin and HDL-C levels (median: 1.04 vs.
1.20 mmol/L, p = 0.0038) were significantly lower in GD
males compared to GND males by the Wilcoxon test (all
data are shown on Fig. 1, except for HLD-C). No differ-
ence was noted in the female group for any of these vari-
ables, except for IL-6 which was somewhat lower
although not significantly different in GD compared to
GND females (median: 2.28 vs. 1.62 ng/mL, p = 0.063).
Scatter plots with Spearman correlation coefficients
are shown in Fig. 2 between M3, HIRIOGTT, TG, abdominal
circumference (i.e. major components of metabolic syn-
drome) and ALT. Furthermore, simple bivariate and partial
correlation coefficients are listed in Table 2 between liver
enzymes (AST, ALT and GGT) and metabolic parameters
(including M3, HIRI, blood sugar level, insulin secretion,
lipids and adipocytokines), after correcting for age, BMI, al-
cohol consumption, HbA1c, abdominal circumference (and
FSH in females). In males triglyceride, HDL-cholesterol,enzymes, in age and BMI matched GD and GND males and females.
n GD and GND groups with Wilcoxon test (GD males n = 26, GND
ces were measured between age, BMI, abdominal circumference
itivity (M3), OGTT-glucose, estradiol, testosterone and FSH levels did
derate alcohol consumption was excluded. In age and BMI matched
GND males. Further significant differences were found in HDL-C in
was border significant (p = 0.063)
Fig. 2 Scatter plots for bivariate correlations between liver enzymes and component of metabolic syndrome. Scatter plots in men (black spots)
and women (red spots) representing bivariate (Spearman) correlations between HIRI, M3, basal glucose, TG, AC and liver enzymes (ALT, AST, GGT).
Correlation coefficients are indicated in black (men), and in red (women). Correction done for BMI, age, HBA1c, genetic disposition and alcohol
consumption. Significance level of each correlation is further indicated *: p < 0.05, **: p < 0.01, ***: p < 0.001, ****: p < 0.0001
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ALT (and AST) after adjusting with the above confounding
factors, while in females it is the clamp measured glucose
uptake per se along with blood sugar values that stay sig-
nificantly related after correction is done (see Fig. 2 and
Table 2). GGT is rather non sex-specific, i.e. corrected asso-
ciations with GGT show a similar pattern in both genders.
Feature selection analysis (Boruta algorithm) con-
firmed the difference between sexes (Fig. 3 and Fig. 4).
The analysis was carried out separately in males and fe-
males to determine the list of ‘important attributes’ for
M3, determined by the “Z” value (axis Y: mean, median,
minimum and maximum values). ALT proved to be an
‘important’ attribute for M3 only in females besides BMI,
BFP, AC, serum insulin and FFA levels (“Z” values see
on Fig. 3). In men, on the other hand, none of the trans-
aminase levels, instead leptin, diastolic blood pressure,
TG, serum glucose and age were confirmed as ‘import-
ant variables’ besides AC, serum insulin, BFP, BMI and
FFA which were common with the female group (Fig. 4).
Multiple regression analysis was conducted in order to
determine the ability of the ‘important’ attributes to esti-
mate the M3 values both in male and female subjects.Model for women: y ~ b0 + b1x1 + b2x2 +…+ b5x5, where
response variable y is M3, and explanatory variables x1, …, x5
are BMI, AC, Insulin, fasting FFA, ALT, respectively, and
coefficients are in Table 3. The intercept b0 is the expected
mean value of M3 when all xi = 0. The results in Table 3
show that F = 29.95 (p < 2.2e-16), indicating that the vari-
ables collectively have a significant effect on M3, ALT and
BMI being significant independent predictors.
Model for men: y ~ b0 + b1x1 + b2x2 +…+ b9x9, where
response variable y is M3, and explanatory variables x1, …, x9
are AC, Leptin, BMI, Insulin, TG, FFA, Glucose, RR_Dias
(diastolic blood pressure) and Age, respectively, and coeffi-
cients b1…b9 are in Table 4. The intercept b0 is the ex-
pected mean value of M3 when all xi = 0. The results in
Table 4 show that F = 14.71 (p < 2.36e-16), indicating that
the variables collectively have a significant effect on M3,
serum insulin and leptin being the significant independent
predictors.
The ability of the ‘important’ attributes to predict mea-
sured M3 is indicated in Fig. 5 for women, and in Fig. 6 for
men, where linear regression scatter plots for fitted vs. mea-
sured M3 values are shown. The regression model gave an
excellent estimation of M3 in women, less so in men.
Table 2 Bivariate correlations adjusted for confounding factors between metabolic parameters and liver enzymes in male and female subjects
AST (U/L) ALT (U/L) GGT (U/L)
Males Females Males Females Males Females
R Partial R R Partial R R Partial R R Partial R R Partial R R Partial R
HbA1c (%) n.s. n.s. n.s. n.s. n.s. n.s. 0.204* n.s. n.s. n.s. 0.229** n.s.
Glu-0 (mmol/L) 0.244** n.s. n.s. n.s. 0.268*** n.s. 0.31**** 0.177* 0.360**** 0.25** 0.335**** 0.214***
AIR (uU/mL) −0.181* n.s. n.s. n.s. −0.189* −0.201* n.s. n.s. −0.181* n.s. n.s. n.s.
FFA-0 (mmol/L) 0.326**** 0.234* 0.206* n.s. 0.295*** 0.203* 0.276** n.s. 0.385**** 0.185* 0.277*** 0.198*
M3 (mg/min/kg) −0.167* n.s. −0.311**** 0.216*** −0.324**** n.s. −0.430**** −0.270*** −0.323**** n.s. −0.337**** −0.268***
HIRI n.s. n.s. n.s. n.s. 0.198* n.s. 0.231** n.s. 0.193* n.s. 0.240** n.s.
TG (mmol/L) 0.389**** 0.315*** 0.201* n.s. 0.444**** 0.288** 0.216** n.s. 0.636**** 0.525**** 0.299**** 0.200*
HDL-C (mmol/L) n.s. n.s. n.s. n.s. −0.255** −0.218* n.s. n.s. n.s. n.s. n.s. n.s.
LDL-C (mmol/L) n.s. n.s. n.s. n.s. 0.168* n.s. n.s. n.s. 0.330**** 0.244** 0.167* n.s.
Leptin (ng/mL) n.s. n.s. 0.239** 0.198* 0.288*** n.s. 0.166* n.s. 0.292*** n.s. n.s. n.s.
Adiponectin (ug/mL) n.s. n.s. n.s. n.s. −0.219** n.s. n.s. n.s. −0.164* n.s. n.s. n.s.
IL-6 (ng/mL) 0.180* n.s. n.s. n.s. n.s. n.s. n.s. n.s. 0.245** n.s. n.s. n.s.
Significant Partial correlations are indicated after adjustment for age, BMI, abdominal circumference, body fat percent and alcohol consumtion. In females bivariate correlations are also corrected for FSH levels.
*: <0.05, **: <0.01, ***: <0.001, ****: <0.0001
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Fig. 3 Feature selection (Boruta algorithm) analysis for M3 in women. Important attributes are marked in green: BMI, fat percentage, abdominal
circumference, insulin, basal FFA (IVFFA_0) and ALT (mean Z: 18.46, 12.04, 9.34, 5.76 and 3.85, respectively). Yellow and red columns represent attributes
that were rejected or ‘tentative’ as being important for M3: these are (in order of importance): serum-bilirubin, small-dense LDL, alkaline phosphatase,
systolic blood pressure, triglyceride, GGT, fasting glucose, HbA1c, leptin, adipoectin, AST, total-LDL-cholesterol, age, alcohol consumption, VLDL,
total-cholesterol, genetic predisposition, LDL-1 subclass, HDL subclass, diastolic blood pressure, creatinin, white blood cell count. Mean, median,
minimum and maximum Z values are represented on ‘Y’ axis
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In our paper we have investigated the sex specific connection
between liver function tests (ALT, AST, GGT) and insulin
sensitivity measured by the gold-standard clamp method.
Our main result was to demonstrate that ALT – although
being in strong bivariate correlation with clamp-measuredFig. 4 Feature selection (Boruta algorithm) analysis for M3 in men. Important
percentage, leptin, BMI, diastolic blood pressure, TG, basal FFA, serum glucose
and 4.11, respectively). Yellow and red columns represent attributes that were
importance): systolic blood pressure, GGT, total cholesterol, alcohol consumpt
AST, genetic predisposition, alkaline phosphatase, HDL %, ALT, white bloo
‘shadow attributes’. Mean, median, minimum and maximum Z values areglucose uptake in both sexes – is an independent pre-
dictor of muscle glucose uptake in women but not in men.
Gender specific aspects of NAFLD and cardiovascular risk
Many studies have previously demonstrated that ALT,
AST and GGT levels independently predict type 2 diabetesattributes are marked in green: abdominal circumference, insulin, body fat
and age (mean Z values: 16.65, 13.08, 12.19, 11.77, 6.12, 6.00, 5.39, 4.92
rejected or ‘tentative’ as being important for M3. These are (in order of
ion, small-dense LDL %, adiponectin, serum-bilirubin, HbA1c, total-LDL %,
d cell count, LDL-1 %, creatinin, VLDL %. Blue columns represent
represented on ‘Y’ axis
Table 3 Multiple regression analysis for clamp M3 in women
Coefficients: Estimate Std. error t value Pr (>|t|)
(Intercept) 15.81509 1.22936 12.864 < 2e-16***
BMI −0.23375 0.05272 −4.434 1.9e-05***
AC −0.01780 0.02081 −0.856 0.39377
Insulin −0.04213 0.02469 −1.706 0.09028.
IVFFA_0 −1.00410 0.56730 −1.770 0.07899.
ALT − 0.03159 0.01208 −2.616 0.00991**
Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘’ 1
Residual standard error: 1.88 on 158° of freedom
Multiple R-squared: 0.5259, Adjusted R-squared: 0.5084
F-statistic: 29.95 on 5 and 135 DF, p-value: < 2.2e-16
Fig. 5 Linear regression for original vs. fitted M3 values in women
estimated by multiple regression analysis for attributes determined by
Feature Selection: BMI (p = 1.9e-05), AC (p = 0.39377), serum-insulin
(p = 0.09028), serum-FFA (p = 0.07899), ALAT (p = 0.00991). Multiple
R-squared: 0.5259, Adjusted R-squared: 0.5084
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been shown to be associated with indirect measurements
of insulin resistance, including fasting insulin levels and
HOMA-IR [9, 24], and were also shown to be in conjunc-
tion with insulin sensitivity measured by the gold-standard
clamp method [11]. Liver fat accumulation is closely re-
lated to liver function changes, especially ALT, therefore
this enzyme is commonly used as a biomarker of
NAFLD [28, 29]. Both NAFLD and T2DM have some
gender aspects. Most of the studies published in this
field have found that NAFLD is more common amongst
men [2, 30–33]. Ayonrinde et al. have found that al-
though the prevalence is higher in women than in men,
men diagnosed with NAFLD had a more severe meta-
bolic phenotype with higher blood glucose levels and
systolic blood pressure, lower adiponectin and high-
density lipoprotein cholesterol and a greater level of
liver injury measures (ALT and AST levels) [34]. This
supports the notion that globally deteriorating meta-
bolic state appears to develop faster in men, independ-
ently of the presence of NAFLD. This is supported by
the finding that ALT above 40U/L was an independent
predictor of coronary heart disease (CHD) only in theTable 4 Multiple regression analysis for clamp M3 in men
Coefficients: Estimate Std. Error t value Pr (>|t|)
(Intercept) 19.30144 2.35704 8.189 1.9e-13***
AC −0.03122 0.02886 −1.082 0.2813
Leptin −0.09451 0.04291 −2.202 0.0294*
BMI −0.07101 0.08879 −0.800 0.4253
Insulin −0.09684 0.04147 −2.335 0.0210*
Tg −0.07363 0.12927 −0.570 0.5699
IVFFA_0 −0.69004 0.58016 −1.189 0.2364
Glucose −0.37848 0.23299 −1.624 0.1067
RR_Dias −0.01234 0.02586 −0.477 0.6340
Age −0.03591 0.01828 −1.964 0.0516
Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘’ 1
Residual standard error: 2.331 on 148° of freedom
Multiple R-squared: 0.4989, Adjusted R-squared: 0.465
F-statistic: 14.71 on 9 and 133 DF, p-value: 2.368e-16male population in a recent study [4]. Although our re-
sults do not directly confirm this finding, the strong asso-
ciations between ALT and abnormal lipid levels (TG and
HDL-C) being independent from other confounding fac-
tors, which were absent in females could support these
data, as atherogenic dyslipidemia is a major risk factor for
CHD. Further sex-specific changes were noted in adipo-
nectin and HDL-C levels of male subjects with diabetic
relatives, both parameters being strong independent pre-
dictors of coronary disease. Even at a relatively youngerFig. 6 Linear regression for original vs. fitted M3 values in men
estimated by multiple regression analysis for attributes determined
by FS: AC (p = 0.2813), leptin (p = 0.0294), BMI (p = 0.4253), serum-
insulin (p = 0.0210), triglyceride (p = 0.5699), serum-FFA (p = 0.2364),
serum-glucose (p = 0.1067), diastolic RR (p = 0.6340), age (p = 0.0516).
Multiple R-squared: 0.4989, Adjusted R-squared: 0.465
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cantly lower adiponectin, HDL-C and IL-6 levels than
genetically not predisposed men, along with higher ALT
values. This finding is consistent with the results of Feitosa
et al. [4] and is not influenced by the fact that transamin-
ase levels are usually lower in females than in males, as
amongst all NGT subjects male and female data did not
differ substantially (see Table 1). Although the primary
aim of our study was to characterize sex specific features
of the hepatic-metabolic relationship by analyzing group
differences and associations rather within than between
sexes, sex specific variations in transaminase levels seem
to be stronger in GI than in NGT subjects (see in Table 1).
This finding might be in association with that of Feitosa
et al., i.e. the independent predictive value of ALT for
CHD was stronger in NGT than in GI men [4].
Gender aspects of prediabetic state, fat distribution and
ALT
T2DM prevalence is higher among men than in women,
especially in the middle-aged population [35, 36]. More-
over, men are diagnosed with T2DM at lower BMI than
women [2]. This can be partially explained by the fact
that women can remain highly insulin sensitive despite
considerable weight gain as they appear to have an ex-
cellent ability to expand the safer subcutaneous fat
stores [6]. In men, subcutaneous fat storage capacity is
significantly lower, driven predominantly by differential
sex hormone settings, thus with weight gain excess fat is
placed more rapidly into other tissues in men, such as in
intra-abdominal, perivascular, skeletal muscle, liver and
pancreatic areas, the process being indicated by a rise in
ALT and GGT along with dyslipidaemia [1].
The results of GD vs. GND group comparison (Fig. 1)
suggest that progressively worsening metabolic state in-
dicated by the presence of abnormal metabolic bio-
markers characteristic of the prediabetic stage is indeed
gender specific to some extent. We cannot exclude the
idea that the mutual genetic background behind MetS
and increased susceptibility to NAFLD [37] might be at
least partially gender specific as well, although cross-
sectional data would not be appropriate for drawing
such a conclusion, and this notion needs further studies.
The rise of ALT and GGT, which is an indicator of
liver fat accumulation, might indicate a global metabolic
deterioration in men, i.e. a severe insulin-resistant state,
which is further aggravated by NAFLD. The manifest-
ation of glucose intolerance with or without insulin re-
sistance is still compensated by the favourable hormonal
environment in women, where the accumulation of
intra-abdominal/visceral (liver) tissue fat is delayed by
the existence of increased subcutaneous fat stores,
blocking further metabolic aggravation. This theory is
supported by the finding of Kang et al., who reportedthat the difference in ALT levels were more pronounced
between normal weight obese (NWO) male and normal
weight lean (NWL) male subjects than between NWO
and NWL female subjects, albeit the difference was not
statistically significant [38].
Similarly, the strong and independent association be-
tween FFA, TG, HDL-C and ALT in our study was only
present in men and not in women, which is in accord-
ance with the above theory. We also emphasise that
female subjects were both pre- and postmenopausal at
the time of the enrollment, which could at least partly
explain these results, however data were corrected for
age and FSH as well. Another confounding factor that
could have influenced our results is the menarcheal age
of the enrolled women, since earlier menarche was asso-
ciated with elevated ALT, TG and CRP levels as well as
increased risk of diabetes in a Brazilian study [39]. This
finding needs to be further evaluated, because these data
were not available in our study.
Insulin sensitivity and liver enzymes
One of the most important findings of our study in this
healthy/prediabetic population is that after the adjustment
for confounding factors such as age, BMI, abdominal cir-
cumference, body fat percent, HbA1c, alcohol consump-
tion (and FSH levels in women), all three liver enzymes
(ALT, AST and GGT) stayed significantly associated with
clamp-measured insulin sensitivity (i.e. muscle glucose up-
take) in women but disappeared in men. This difference
was only applicable for the gold standard clamp measured
peripheral insulin sensitivity, i.e. the association with the
estimated OGTT derived HIRI index (although stronger
in females than in males) disappeared in both genders
after the correction was done (see Fig. 2 and Table 2).
Analyzing data from the other aspect, a feature selec-
tion analysis-based multiple regression model has found
that ALT was a significant independent predictor of
clamp insulin sensitivity besides BMI in females. In men,
this was fasting insulin and leptin but not liver enzyme
levels.
Those studies confirming the independent association be-
tween ALT and directly measured insulin sensitivity (clamp
or minimal model analysis) were carried out on either
healthy, prediabetic or diabetic mixed-gender populations,
although results stayed significant after the adjustment for
sex and other confounding factors [11, 14]. In the study of
Kawamoto et al. in a non-obese, middle-aged, mixed-
gender population, the ALT/AST ratio was a better pre-
dictor of HOMA-IR than fasting insulin levels in both sexes
[16], although in our study we did not examine the role of
ALT/AST ratio. Schneider et al. did not find any sex-
specific difference in the association between liver enzymes
and diabetes risk. Higher ALT, AST and especially GGT
predicted the incidence of diabetes in both genders [40].
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elevation predicted insulin resistance better than the exist-
ence of metabolic syndrome in males; however no female
subjects were involved in this study [12]. Similarly, sub-
jects with low HDL-C had higher ALT levels and in-
creased insulin resistance (measured by the HOMA
index) than subjects with high HDL-C levels, albeit no sex
difference was noted [41].
On the other hand several studies have described clear
gender differences in this respect. Lee et al. have described
a gender difference in an adolescent population. Obesity
and triglyceride were the major determinants of HOMA-IR
in boys, and obesity and GGT in girls [17]. Furthermore,
the independent association with IR and ALT was stronger
in girls than in boys (P = 0.034 vs. P = 0.005) [17]. Poutschi
et al. found a significant (p < 0.0001) linear relationship be-
tween age and ALT only in females but not in males [42]
As insulin resistance increases with age, the clamp M3 –
ALT independent association found only in females in our
study might be contributed to this finding, even if adjust-
ments were always done for age. In the PET CT study of
Kang et al., the difference between ALT levels were more
pronounced between normal weight obese and normal
weight lean subjects in the male than in the female group,
albeit this difference was not statistically significant [38].
A higher glutamate and glutamate/glutamine ratio, a re-
sult of abnormal ALT and AST activity was significantly
associated with lower high-density lipoprotein (HDL) in
women but not in men in the metabolomic study of
Cheng et al. [43]. No other significant effect modification
by sex was noted in the significant association between se-
lect metabolites (glutamine, glutamate and their ratio) and
components of insulin-resistant phenotype.
Our results support the hypothesis that a very delicate
sex difference exists in the progression/association of
NAFLD with metabolic parameters in the adult population
and this has an important clinical implication. In women, it
is clearly evident that insulin resistance per se might indi-
cate liver fat accumulation, and vice versa, elevated ALT
levels might indicate decreased insulin sensitivity earlier
than fasting insulin, lipoprotein or adipokine levels. In men,
ALT (also AST and GGT) elevations coexist with other
metabolic changes followed/caused by insulin resistance.
Therefore liver enzyme elevation per se is not an indicator
of decreased insulin sensitivity but a general metabolic de-
terioration along with insulin resistance in men, with no in-
dependent associations with the clamp M3 value.
The mechanism of these findings might be complex.
The previously mentioned sex difference in fat distribution
leads to increased susceptibility to intra-abdominal, vis-
ceral and liver fat accumulation in men, which is at least
partially driven by differential sex hormone settings [1]. A
further explanation and/or consequence is the sexual
dimorphism displayed by liver-associated markers, such assex hormone-binding globulin (SHBG) and adiponectin
levels being much lower in men, consistent with their
greater insulin resistance and greater risk of diabetes and
cardiovascular disease at a younger age [44, 45] and the
more severe metabolic phenotype at the diagnosis of
NAFLD [32]. This is in agreement with the ealier men-
tioned finding of Feitosa et al., that ALT is a significant
independent predictor of coronary heart disease in men
but not in women, with the association being stronger in
non-diabetic men [4].
ALT as clamp index
There is another aspect to our findings, namely that
slightly elevated ALT may strongly indicate the presence
of insulin resistance in females even without hyperinsuli-
nemia, especially in overweight women. Hence, the use
of ALT in estimating clamp measured insulin sensitivity
might be more relevant in females, while that of fasting
insulin-based indices (i.e. the HOMA model) physiolo-
gically seems to be more appropiate in males according
to our results. A gender (and racial) difference in the
utility of insulin-based fasting and OGTT-based models
has recently been described by Pisprasert et al., who
found that gender as well as race, had a significant effect
on explaining the predictability of clamp-measured glu-
cose disposal rates (GDR) [46].
Limitations of the study
Our study has several limitations. First, based on its cross-
sectional study design, the present findings are inherently
limited in the ability to eliminate causal relationships be-
tween ALT and insulin resistance or sensitivity. Second,
since some of the study population had several risk factors,
including hypertension, and dyslipidemia, we could not
eliminate the possible confounding effect of underlying dis-
eases on the present findings, although the prevalence of
controlled hypertension, smoking and dyslipidemia were
similar throughout the male and female groups. Since the
original research primarily aimed the elucidation of the
early diagnosis of insulin resistance rather than its associ-
ation with liver disease, HVC and HBV serology was not
tested at screening, so the confounding effect of latent
hepatitis could not have been excluded. On the other hand
the prevalence of virus carriers is low in Hungary (between
0.7-1.3 % for HCV and under 2 % for HBV) which might
have had only minimal effects on the results.
Conclusions
In our study we found that the association between liver
function tests and insulin sensitivity is gender specific:
muscle glucose uptake measured by the gold-standard
hyperinsulinemic euglycemic clamp is independently
predicted by the ALT values only in females, so ALT can
be used as an indirect measure of insulin sensitivity,
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ity was independently predicted only by fasting insulin
and leptin levels, while the relationship with liver enzymes
ceased after correction for confounding factors. Based on
our results and the findings of other studies, in male pa-
tients liver fat accumulation indicated by ALT elevation is
part of a general metabolic deterioration that includes, but
is not limited to decreased insulin sensitivity. Therefore,
ALT might be indeed an independent predictor of cardio-
vascular risk in men rather than in women.
Further prospective population-based studies are
needed to investigate the mechanisms in order to answer
these questions. This has an important clinical implica-
tion in the early diagnosis of insulin resistance and the
further prevention of MetS, NAFLD and their cardiovas-
cular complications.
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